全球幽門螺旋桿菌診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計幽門螺旋桿菌診斷市場將從 2025 年的 7.6237 億美元成長到 2034 年的 13.023 億美元，2026 年至 2034 年的複合年成長率為 6.13%。

由於全球胃部感染疾病、潰瘍和胃癌的盛行率不斷上升，全球幽門螺旋桿菌診斷市場正經歷穩定成長。人們對早期診斷和預防醫學的認知不斷提高，促使檢測量增加。呼吸檢測和糞便抗原檢測等非侵入性診斷方法的日益普及進一步推動了市場擴張。此外，新興經濟體醫療基礎設施的改善也使人們更容易獲得先進的診斷服務。

關鍵成長要素包括診斷試劑盒的技術進步、醫療費用支出增加以及政府支持的篩檢項目。醫院和診斷檢查室對準確快速的診斷解決方案的需求日益成長。生活方式的改變、不健康的飲食習慣以及胃腸道疾病病例的增加也促進了檢測量的成長。此外，分子診斷技術的整合提高了檢測的準確性，並推動了檢測方法的普及。

展望未來，在就地檢驗和個人化醫療方法持續創新的推動下，市場預計將穩定成長。醫療保險覆蓋範圍的擴大和對預防醫學的日益重視將創造新的機會。由於健康意識的提高和醫療設施的改善，亞太和拉丁美洲等新興市場的需求預計將十分強勁。整體而言，隨著早期檢測成為全球醫療保健策略的重中之重，市場前景仍然光明。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球幽門螺旋桿菌診斷市場：按類型分類

• 市場分析、洞察與預測
• 裝置
• 試劑
• 服務

第5章 全球幽門螺旋桿菌診斷市場：依技術分類

• 市場分析、洞察與預測
• 免疫檢測
• POC
• 分子診斷

第6章 全球幽門螺旋桿菌診斷市場：依最終使用者分類

• 市場分析、洞察與預測
• 醫院
• 診斷檢查室
• 診所

第7章 全球幽門螺旋桿菌診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific
  • Biohit Oyj
  • Quest Diagnostics Incorporated
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Alpha Laboratories Ltd
  • F. Hoffmann-La Roche Ltd
  • Coris BioConcept
  • Certest Biotec
  • Epitope Diagnostics Inc

The Helicobacter Pylori Diagnostics Market size is expected to reach USD 1302.30 Million in 2034 from USD 762.37 Million (2025) growing at a CAGR of 6.13% during 2026-2034.

The Global Helicobacter Pylori Diagnostics Market is witnessing steady growth due to the rising prevalence of gastric infections, ulcers, and stomach cancer worldwide. Increasing awareness about early diagnosis and preventive healthcare is encouraging more people to undergo testing. The growing availability of non-invasive diagnostic methods, such as breath tests and stool antigen tests, has further supported market expansion. In addition, improved healthcare infrastructure in emerging economies is boosting access to advanced diagnostic services.

Key growth drivers include technological advancements in diagnostic kits, rising healthcare spending, and supportive government screening programs. The demand for accurate and rapid diagnostic solutions is increasing among hospitals and diagnostic laboratories. Lifestyle changes, poor dietary habits, and increasing cases of gastrointestinal disorders are also contributing to higher testing volumes. Moreover, the integration of molecular diagnostic techniques is enhancing detection accuracy and driving adoption.

Looking ahead, the market is expected to grow consistently with continuous innovation in point-of-care testing and personalized medicine approaches. Expanding healthcare coverage and increasing focus on preventive care will create new opportunities. Emerging markets in Asia-Pacific and Latin America are likely to witness strong demand due to improving awareness and medical facilities. Overall, the future outlook remains positive as early detection becomes a priority in global healthcare strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Instruments
• Reagents
• Services

By Technology

• Immunoassays
• POC
• Molecular Diagnostics

By End-user

• Hospitals
• Diagnostics Laboratories
• Clinics

COMPANIES PROFILED

• Thermo Fisher Scientific, Biohit Oyj, Quest Diagnostics Incorporated, Meridian Bioscience, BioRad Laboratories, Alpha Laboratories Ltd, F HoffmannLa Roche Ltd, Coris BioConcept, Certest Biotec, Epitope Diagnostics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. POC Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Technology
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Technology
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Technology
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Technology
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Technology
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HELICOBACTER PYLORI DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific
  • 9.2.2 Biohit Oyj
  • 9.2.3 Quest Diagnostics Incorporated
  • 9.2.4 Meridian Bioscience
  • 9.2.5 Bio-Rad Laboratories
  • 9.2.6 Alpha Laboratories Ltd
  • 9.2.7 F. Hoffmann-La Roche Ltd
  • 9.2.8 Coris BioConcept
  • 9.2.9 Certest Biotec
  • 9.2.10 Epitope Diagnostics Inc